Global Inactivated Polio Vaccine (IPV) Market - Industry Analysis by Player, Region, Type, Application and Sales Channel, Forecast

Chapter 1 Inactivated Polio Vaccine (IPV) Market Overview

1.1 Inactivated Polio Vaccine (IPV) Definition

1.2 Global Inactivated Polio Vaccine (IPV) Market Size Status and Outlook (2019-2032)

1.3 Global Inactivated Polio Vaccine (IPV) Market Size Comparison by Region (2019-2032)

1.4 Global Inactivated Polio Vaccine (IPV) Market Size Comparison by Type (2019-2032)

1.5 Global Inactivated Polio Vaccine (IPV) Market Size Comparison by Application (2019-2032)

1.6 Global Inactivated Polio Vaccine (IPV) Market Size Comparison by Sales Channel (2019-2032)

1.7 Inactivated Polio Vaccine (IPV) Market Dynamics

1.7.1 Market Drivers/Opportunities

1.7.2 Market Challenges/Risks

1.7.3 Market News (Products Launch, Mergers, Acquisitions, Expansion, Agreement and Collaborations, Partnerships)

1.7.4 COVID-19 Impacts

1.7.5 Russia-Ukraine War Impacts

1.7.6 US-Israel-Iran War Impacts

Chapter 2 Executive Summary

2.1 Global Inactivated Polio Vaccine (IPV) Market Snapshot

2.2 Global Inactivated Polio Vaccine (IPV) Market Volume & Revenue 2019-2025

2.3 Global Inactivated Polio Vaccine (IPV) Market Differential Growth Potential Analysis by Type, 2019-2032 (USD Million)

2.4 Global Inactivated Polio Vaccine (IPV) Market Differential Growth Potential Analysis by Application, 2019-2032 (USD Million)

2.5 Global Inactivated Polio Vaccine (IPV) Market Differential Growth Potential Analysis by Sales Channels, 2019-2032 (USD Million)

2.6 Global Inactivated Polio Vaccine (IPV) Market Differential Growth Potential Analysis by Region, 2019-2032 (USD Million)

Chapter 3 Inactivated Polio Vaccine (IPV) Market Segment Analysis by Player

3.1 Global Inactivated Polio Vaccine (IPV) Sales and Market Share by Player (2023-2025)

3.2 Global Inactivated Polio Vaccine (IPV) Revenue and Market Share by Player (2023-2025)

3.3 Global Inactivated Polio Vaccine (IPV) Average Price by Player (2023-2025)

3.4 Players Competition Situation & Trends (2023-2025)

3.5 Conclusion of Segment by Player

Chapter 4 Inactivated Polio Vaccine (IPV) Market Segment Analysis by Type

4.1 Global Inactivated Polio Vaccine (IPV) Market by Type

4.1.1 Mahoney

4.1.2 MEF1

4.1.3 Saukett

4.2 Global Inactivated Polio Vaccine (IPV) Sales and Market Share by Type (2019-2025)

4.3 Global Inactivated Polio Vaccine (IPV) Revenue and Market Share by Type (2019-2025)

4.4 Global Inactivated Polio Vaccine (IPV) Average Price by Type (2019-2025)

4.5 Leading Players of Inactivated Polio Vaccine (IPV) by Type in 2025

4.6 Conclusion of Segment by Type

Chapter 5 Inactivated Polio Vaccine (IPV) Market Segment Analysis by Application

5.1 Global Inactivated Polio Vaccine (IPV) Market by Application

5.1.1 Public

5.1.2 Private

5.2 Global Inactivated Polio Vaccine (IPV) Revenue and Market Share by Application (2019-2025)

5.3 Leading Consumers of Inactivated Polio Vaccine (IPV) by Application in 2025

5.4 Conclusion of Segment by Application

Chapter 6 Inactivated Polio Vaccine (IPV) Market Segment Analysis by Sales Channel

6.1 Global Inactivated Polio Vaccine (IPV) Market by Sales Channel

6.1.1 Global Inactivated Polio Vaccine (IPV) Market, by Direct Channel Market Analysis 2019-2032 (USD Million)

6.1.2 Global Inactivated Polio Vaccine (IPV) Market, by Distribution Channel Market Analysis 2019-2032 (USD Million)

6.2 Global Inactivated Polio Vaccine (IPV) Revenue and Market Share by Sales Channel (2019-2025)

6.3 Leading Distributors/Dealers of Inactivated Polio Vaccine (IPV) by Sales Channel in 2025

6.4 Conclusion of Segment by Sales Channel

Chapter 7 Inactivated Polio Vaccine (IPV) Market Segment Analysis by Region

7.1 Global Inactivated Polio Vaccine (IPV) Market Size and CAGR by Region (2019-2032)

7.2 Global Inactivated Polio Vaccine (IPV) Sales and Market Share by Region (2019-2025)

7.3 Global Inactivated Polio Vaccine (IPV) Revenue and Market Share by Region (2019-2025)

7.4 North America

7.4.1 North America Market by Country

7.4.2 North America Inactivated Polio Vaccine (IPV) Market Share by Type

7.4.3 North America Inactivated Polio Vaccine (IPV) Market Share by Application

7.4.4 United States

7.4.5 Canada

7.4.6 Mexico

7.5 Europe

7.5.1 Europe Market by Country

7.5.2 Europe Inactivated Polio Vaccine (IPV) Market Share by Type

7.5.3 Europe Inactivated Polio Vaccine (IPV) Market Share by Application

7.5.4 Germany

7.5.5 United Kingdom

7.5.6 France

7.5.7 Italy

7.5.8 Russia

7.5.9 Spain

7.5.10 Benelux

7.5.11 Poland

7.5.12 Austria

7.5.13 Portugal

7.5.14 Rest of Europe

7.6 Asia-Pacific

7.6.1 Asia-Pacific Market by Country

7.6.2 Asia-Pacific Inactivated Polio Vaccine (IPV) Market Share by Type

7.6.3 Asia-Pacific Inactivated Polio Vaccine (IPV) Market Share by Application

7.6.4 China

7.6.5 Japan

7.6.6 Korea

7.6.7 India

7.6.8 Southeast Asia

7.6.9 Australia

7.6.10 Taiwan

7.6.11 Rest of Asia Pacific

7.7 South America

7.7.1 South America Market by Country

7.7.2 South America Inactivated Polio Vaccine (IPV) Market Share by Type

7.7.3 South America Inactivated Polio Vaccine (IPV) Market Share by Application

7.7.4 Brazil

7.7.5 Argentina

7.7.6 Colombia

7.7.7 Chile

7.7.8 Peru

7.7.9 Venezuela

7.7.10 Rest of South America

7.8 Middle East & Africa

7.8.1 Middle East & Africa Market by Country

7.8.2 Middle East & Africa Inactivated Polio Vaccine (IPV) Market Share by Type

7.8.3 Middle East & Africa Inactivated Polio Vaccine (IPV) Market Share by Application

7.8.4 UAE

7.8.5 Saudi Arabia

7.8.6 South Africa

7.8.7 Egypt

7.8.8 Nigeria

7.8.9 Rest of Middle East & Africa

7.9 Conclusion of Segment by Region

Chapter 8 Profile of Leading Inactivated Polio Vaccine (IPV) Players

8.1 Bibcol

8.1.1 Company Snapshot

8.1.2 Product/Service Offered

8.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.1.4 Recent Developments

8.2 Serum Institute

8.2.1 Company Snapshot

8.2.2 Product/Service Offered

8.2.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.2.4 Recent Developments

8.3 Tiantan Biological

8.3.1 Company Snapshot

8.3.2 Product/Service Offered

8.3.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.3.4 Recent Developments

8.4 IMBCA

8.4.1 Company Snapshot

8.4.2 Product/Service Offered

8.4.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.4.4 Recent Developments

8.5 Panacea Biotec

8.5.1 Company Snapshot

8.5.2 Product/Service Offered

8.5.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.5.4 Recent Developments

8.6 Bio-Med

8.6.1 Company Snapshot

8.6.2 Product/Service Offered

8.6.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.6.4 Recent Developments

8.7 Halfkin Bio-Pharmaceuticals

8.7.1 Company Snapshot

8.7.2 Product/Service Offered

8.7.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.7.4 Recent Developments

Chapter 9 Upstream and Downstream Analysis of Inactivated Polio Vaccine (IPV)

9.1 Industrial Chain of Inactivated Polio Vaccine (IPV)

9.2 Upstream of Inactivated Polio Vaccine (IPV)

9.2.1 Raw Materials (If Applicable)

9.2.2 Manufacturing Cost Structure (If Applicable)

9.2.3 Manufacturing Process (If Applicable)

9.3 Downstream of Inactivated Polio Vaccine (IPV)

9.3.1 Leading Distributors/Dealers of Inactivated Polio Vaccine (IPV)

9.3.2 Leading Consumers of Inactivated Polio Vaccine (IPV)

Chapter 10. Global Inactivated Polio Vaccine (IPV) Market Industry Analysis

10.1. Porter's Five Forces Analysis

10.1.1. Threat of New Entrants

10.1.2. Bargaining Power of Buyers/Consumers

10.1.3. Bargaining Power of Suppliers

10.1.4. Threat of Substitute Types

10.1.5. Intensity of Competitive Rivalry

10.2. Major Growth Avenues within Global Inactivated Polio Vaccine (IPV) Market

10.2.1. Product Types

10.2.2. Applications

10.2.3. Sales Channels

10.2.4. Country

10.3. Inactivated Polio Vaccine (IPV) Industry Ecosystem

10.4. Price Trend Analysis (If Applicable)

10.5. Buying Criteria (If Applicable)

10.6. Regulations (If Applicable)

Chapter 11 Development Trend of Inactivated Polio Vaccine (IPV) (2026-2032)

11.1 Global Inactivated Polio Vaccine (IPV) Market Size (Sales and Revenue) Forecast (2026-2032)

11.2 Global Inactivated Polio Vaccine (IPV) Market Size and CAGR Forecast by Region (2026-2032)

11.3 Global Inactivated Polio Vaccine (IPV) Market Size and CAGR Forecast by Type (2026-2032)

11.4 Global Inactivated Polio Vaccine (IPV) Market Size and CAGR Forecast by Application (2026-2032)

11.5 Global Inactivated Polio Vaccine (IPV) Market Size and CAGR Forecast by Sales Channel (2026-2032)

Chapter 12. Import - Export Analysis (If Applicable)

12.1 North America Inactivated Polio Vaccine (IPV) Import-Export, 2019-2025

12.2 Europe Inactivated Polio Vaccine (IPV) Import-Export, 2019-2025

12.3 Asia Pacific Inactivated Polio Vaccine (IPV) Import-Export, 2019-2025

12.4 South America Inactivated Polio Vaccine (IPV) Import-Export, 2019-2025

12.5 Middle East & Africa Inactivated Polio Vaccine (IPV) Import-Export, 2019-2025

Chapter 13. Demand-Supply Gap Analysis (If Applicable)

13.1 North America Inactivated Polio Vaccine (IPV) Demand-Supply, 2019-2025

13.2 Europe Inactivated Polio Vaccine (IPV) Demand-Supply, 2019-2025

13.3 Asia Pacific Inactivated Polio Vaccine (IPV) Demand-Supply, 2019-2025

13.4 South America Inactivated Polio Vaccine (IPV) Demand-Supply, 2019-2025

13.5 Middle East & Africa Inactivated Polio Vaccine (IPV) Demand-Supply, 2019-2025

Chapter 14 Appendix

14.1 Research Methodology

14.2 Data Sources